Hudson Canyon Capital Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-8,025
| Closed | -$1.86M | – | 56 |
|
|
2024
Q2 | $1.86M | Buy |
8,025
+325
| +4% | +$75.3K | 1.26% | 30 |
|
|
2024
Q1 | $1.66M | Hold |
7,700
| – | – | 1.07% | 45 |
|
|
2023
Q4 | $1.99M | Hold |
7,700
| – | – | 1.45% | 32 |
|
|
2023
Q3 | $1.98M | Buy |
7,700
+2,885
| +60% | +$741K | 1.62% | 22 |
|
|
2023
Q2 | $1.37M | Sell |
4,815
-153
| -3% | -$43.6K | 1.08% | 53 |
|
|
2023
Q1 | $1.38M | Buy |
4,968
+968
| +24% | +$269K | 1.16% | 53 |
|
|
2022
Q4 | $1.11M | Buy |
4,000
+1,250
| +45% | +$346K | 1.02% | 54 |
|
|
2022
Q3 | $734K | Buy |
+2,750
| New | +$734K | 0.73% | 55 |
|
|
2022
Q2 | – | Sell |
-6,027
| Closed | -$1.27M | – | 56 |
|
|
2022
Q1 | $1.27M | Hold |
6,027
| – | – | 1% | 55 |
|
|
2021
Q4 | $1.45M | Sell |
6,027
-298
| -5% | -$71.5K | 1.05% | 54 |
|
|
2021
Q3 | $1.79M | Hold |
6,325
| – | – | 1.38% | 36 |
|
|
2021
Q2 | $2.19M | Sell |
6,325
-25
| -0.4% | -$8.66K | 1.64% | 25 |
|
|
2021
Q1 | $1.78M | Buy |
6,350
+527
| +9% | +$147K | 1.39% | 36 |
|
|
2020
Q4 | $1.43M | Buy |
+5,823
| New | +$1.43M | 1.13% | 55 |
|